Canadian Agency for Drugs and Technologies in Health. (2018). Pharmacoeconomic review report: Tapentadol hydrochloride extended-release tablet (Nucynta extended-release) (Paladin Labs Inc.). Canadian Agency for Drugs and Technologies in Health.
Cita Chicago Style (17a ed.)Canadian Agency for Drugs and Technologies in Health. Pharmacoeconomic Review Report: Tapentadol Hydrochloride Extended-release Tablet (Nucynta Extended-release) (Paladin Labs Inc.). Ottawa (ON): Canadian Agency for Drugs and Technologies in Health, 2018.
Cita MLA (9a ed.)Canadian Agency for Drugs and Technologies in Health. Pharmacoeconomic Review Report: Tapentadol Hydrochloride Extended-release Tablet (Nucynta Extended-release) (Paladin Labs Inc.). Canadian Agency for Drugs and Technologies in Health, 2018.
